Amsterdam-based Neogene Therapeutics Inc., which was founded in 2018, announced May 24 that it has leased 38,000 square feet of space in two buildings in Santa Monica.

SANTA MONICA, Calif.& PHILADELPHIA---- Kite, a Gilead Company, ... Kite to Acquire Tmunity Therapeutics to Pursue Next Generation CAR T-Cell Therapy Advancements in Cancer ...

Kite, a Gilead Company, has agreed to buy Tmunity Therapeutics (Tmunity), a private, clinical-stage biotech focused on cell therapy. The buy-out will further complement Kite’s established in-house ...

Gilead Sciences has bolstered its position in the development of next-generation cancer cell therapies with a deal to absorb Tmunity Therapeutics into its Kite unit.

Kite, a Gilead Sciences unit, announced Tuesday that it will acquire Tmunity Therapeutics and expand its pipeline with the biotech’s next-generation CAR T therapies and technologies.. Kite didn’t ...

Kite Pharma, a Gilead company, has agreed to acquire Tmunity Therapeutics, a clinical-stage biotechnology company focused on next-generation CAR T-therapies. The transaction, announced Dec. 20, is ...

Wainwright has initiated Arcellx with a buy saying that the company'ss CAR-T therapies in development have advantages over marketed ones and its partnership with Gilead will reap benefits.

Kite, a Gilead Company (Nasdaq: GILD), and Tmunity Therapeutics (Tmunity), today announced that the companies have signed an agreement in which Kite will acquire Tmunity, a clinical-stage, private ...

SANTA MONICA, Calif. & PHILADELPHIA, December 20, 2022--Kite, a Gilead Company (Nasdaq: GILD), and Tmunity Therapeutics (Tmunity), today announced that the companies have signed an agreement in which ...